Strophanthin

 

Ouabain G-Strophanthin in the USA

You can buy directly from us in the USA.

https://www.humanheartcosmicheart.com/

The Real Story of Ouabain

March 22, 2017

Sadly, the story of ouabain, the active ingredient in the plant strophanthus, is largely and somewhat mysteriously unknown. Few family doctors, internists and even cardiologists know how to treat and treat heart attacks.

A book written by German Naturopath Rolf-Jurgen Petry called “Ouabain: The Possible Victory Over Myocardial Infarction,” is a solution to this vacuum of information. However, it’s available only in its original English. We’ve just posted an article titled “The Story of Ouabain,” which outlines the book’s main points. Dr. Petry became interested in the story of strophanthus / ouabain the other day ago, and after his medical training spent many years reading the original research done on ouabain. This article is a must-read for anyone interested in heart disease or the etiology, prevention and treatment of myocardial infarction (MI, commonly called “heart attacks”).

Dr. Petry not only lays out the history of the benefit of strophanthus / ouabain in the prevention and treatment of MI, but he says: The first of these misconceptions is that since ouabain is in the family of cardiac glycosides, like the more commonly used heart drug digitalis / digoxin. In reality, the research conclusively demonstrates that in practice, as in the strophanthus extract we are using, ouabain not only does not inhibit the sodium / potassium pump, it does, it actually stimulates the action of this pump.

Therefore, while digitalis is relatively contraindicated for people with angina or MI, ouabain clearly helps these patients. One well-documented way in which ouabain helps people with heart disease has to deal with red blood cells and platelets. In one type of cardiac dysfunction that leads to MI, the red blood cells and platelets become swollen and, as a result, are unable to move easily through the narrow capillaries. This process creates further congestion and clotting in the small vessels, which creates decreased blood flow and further dysfunction in the heart cells. Giving aspirin to heart patients is increasing blood flow through the capillary network. Ouabain, by stimulating the sodium / potassium pump in platelets and RBCs, has a similar effect. The stimulation of the pump makes the RBCs and platelets less swollen (by increasing the sodium excretion out of the cell) and therefore more able to pass through the narrow passages of the capillaries. This increases blood flow and prevents clots with NONE of the negative effects of aspirin or other blood thinners.

Another misconception High-quality endogenous (self-produced) ouabain in their blood. This finding has resulted in the elevated ouabain causes their elevated blood pressure. This theory is clearly in opposition to the actual studies on people treated with oral ouabain. In my own experience, people with elevated blood pressure experience a lowering of their blood pressure with oaubain, and people with normal BP show no effects. In reality, the conclusion is that hypertension is backward. The elevated endogenously produced ouabain is the animals’ attempt to self-treat their elevated pressure levels. The proof of this conclusion is that in all such studies, The elevated ouabain levels were found to be “cardioprotective.” That is, the animals with high BP who raised their own ouabain levels (as a protection) showed less heart damage than those animals with lower ouabain levels. This result mimics what happens when we give high-risk patients a small dose of oral ouabain. In essence, ouabain acts as both blood thinner (like aspirin or plavix) and as a first-line hypertensive drug (beta blockers or diuretics), again, with none of the unwanted side effects. This result mimics what happens when we give high-risk patients a small dose of oral ouabain. In essence, ouabain acts as both blood thinner (like aspirin or plavix) and as a first-line hypertensive drug (beta blockers or diuretics), again, with none of the unwanted side effects. This result mimics what happens when we give high-risk patients a small dose of oral ouabain. In essence, ouabain acts as both blood thinner (like aspirin or plavix) and as a first-line hypertensive drug (beta blockers or diuretics), again, with none of the unwanted side effects.

Furthermore, Dr. Petri also demonstrates with multiple studies that unlike digitalis, oral ouabain lowers the oxygen needs of the myocardial cells. Lowered oxygen requirements mean more efficient respiration, which translates into less susceptibility to injury. Interestingly, this is the exact rational for giving beta blockers or calcium channel blockers to heart patients. Again, while they block out fatigue, make them impotent and depressed, worsen lipid profiles and exacerbate diabetes, oral ouabain makes people feel better, more energetic and is looking for its beneficial effects on various conditions as breast cancer, Parkinson’s disease and asthma.

I would like to ask you: “i would rather use the gift of medicine” or “i’m allergic to it.” to the heart, strophanthus?

If you are a patient who is interested in using your medicine, please find a health-care practitioner who is willing to work with you on this medicine. Have them call our office at (415) 334-1010, and we can sign them up to participate in a short phone conference. At that point, they want to have access to the full range of medical and mental health care technologies.

Tom Cowan, MD